LHRH conjugated gold nanoparticles assisted efficient ovarian cancer targeting evaluated via spectral photon-counting CT imaging: a proof-of-concept research
- 31 January 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 11 (9) , 1916-1928
Abstract
Emerging multifunctional nanoparticulate formulations take advantage of nano-meter scale size and surface chemistry to work as a therapeutic delivery agent and a diagnostic tool for non-invasive real-time monitoring using imaging technologies. Here, we evaluate the selective uptake of 18 nm and 80 nm sized gold nanoparticles (AuNPs) by SKOV3 (4 times higher) ovarian cancer (OC) cells (compared to OVCAR5) in vitro, quantified by inductively coupled plasma (ICP) and MARS spectral photon-counting CT imaging (MARS SPCCT). Based on in vitro analysis, pristine AuNPs (18 nm) and surface modified AuNPs (18 nm) were chosen as a contrast agent for MARS SPCCT. The chemical analysis by FTIR spectroscopy confirmed the luteinizing hormone-releasing hormone (LHRH) conjugation to the AuNPs surface. For the first time, LHRH conjugated AuNPs were used for in vitro and selective in vivo OC targeting. The ICP-MS analysis confirmed preferential uptake of LHRH modified AuNPs by organs residing in the abdominal cavity with OC nodules (pancreas: 0.46 ng mg−1, mesentery: 0.89 ng mg−1, ovary: 1.43 ng mg−1, and abdominal wall: 2.12 ng mg−1) whereas the MARS SPCCT analysis suggested scattered accumulation of metal around the abdominal cavity. Therefore, the study showed the exciting potential of LHRH conjugated AuNPs to target ovarian cancer and also as a potential contrast agent for novel SPCCT imaging technology.Keywords
Funding Information
- Cancer Society of New Zealand (UO-15064)
- Cancer Society of New Zealand (UO-16589)
- Otago School of Medical Sciences (UO-13489)
- Cancer Research Trust New Zealand (GOT-1549-RPG)
This publication has 70 references indexed in Scilit:
- LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian CancerMolecular Pharmaceutics, 2013
- Gold nanoparticles trigger apoptosis and necrosis in lung cancer cells with low intracellular glutathioneJournal of Nanoparticle Research, 2013
- The Medipix3RX: a high resolution, zero dead-time pixel detector readout chip allowing spectroscopic imagingJournal of Instrumentation, 2013
- Biodegradable Polydisulfide Dendrimer Nanoclusters as MRI Contrast AgentsACS Nano, 2012
- Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticlesInternational Journal of Nanomedicine, 2012
- Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering imagesJournal of Nanobiotechnology, 2010
- The Effects of Size, Shape, and Surface Functional Group of Gold Nanostructures on Their Adsorption and Internalization by CellsSmall, 2010
- New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance ImagingPLOS ONE, 2009
- Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and ShapesNano Letters, 2007
- Turkevich Method for Gold Nanoparticle Synthesis RevisitedThe Journal of Physical Chemistry B, 2006